These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. The effect of neuroleptic treatment and of high dosage diazepam therapy on beta-endorphin immunoreactivity in plasma of schizophrenic patients. Gramsch C; Emrich HM; John S; Haas S; Beckmann H; Zaudig M; von Zerssen D J Neural Transm; 1984; 59(2):133-41. PubMed ID: 6144724 [TBL] [Abstract][Full Text] [Related]
43. A neuroendocrinological study of responders and non-responders to ceruletide treatment in chronic neuroleptic-resistant schizophrenia. Moroji T; Okuyama T; Tsunashima K; Matsuzaki I Prog Neuropsychopharmacol Biol Psychiatry; 1987; 11(1):49-64. PubMed ID: 2885895 [TBL] [Abstract][Full Text] [Related]
44. Central monoamine metabolism in depressions. II. Catecholamines and related compounds. van Praag HM Compr Psychiatry; 1980; 21(1):44-54. PubMed ID: 6987035 [No Abstract] [Full Text] [Related]
45. Antipsychotic drug therapy: proceed with caution. Casey G Nurs N Z; 2012 Sep; 18(8):20-4. PubMed ID: 23256335 [No Abstract] [Full Text] [Related]
47. Prediction of response to neuroleptic drug therapy in schizophrenia. Awad AG Can J Psychiatry; 1985 Jun; 30(4):241-2. PubMed ID: 2861885 [No Abstract] [Full Text] [Related]
48. Studies of beta-endorphin in psychiatric patients. Berger PA; Barchas JD Ann N Y Acad Sci; 1982; 398():448-59. PubMed ID: 6297364 [No Abstract] [Full Text] [Related]
49. Metabolic stress effects in normal volunteers and schizophrenic patients. Breier A; Wolkowitz OM; Rapaport M; Paul SM; Pickar D Psychopharmacol Bull; 1988; 24(3):431-3. PubMed ID: 2856418 [No Abstract] [Full Text] [Related]
50. Neuroendocrine and psychological variables relating to post-operative psychosis after open-heart surgery. Naber D; Bullinger M Psychoneuroendocrinology; 1985; 10(3):315-24. PubMed ID: 2932762 [TBL] [Abstract][Full Text] [Related]
51. Neuroendocrine effects of D,L-propranolol. Malas KL; de Fraites EG; van Kammen DP Lancet; 1981 Aug; 2(8243):424. PubMed ID: 6115193 [No Abstract] [Full Text] [Related]
52. Chronic use of opioids and antipsychotic drugs: side effects, effects on endogenous opioids, and toxicity. Kreek MJ; Hartman N Ann N Y Acad Sci; 1982; 398():151-72. PubMed ID: 6130734 [No Abstract] [Full Text] [Related]
54. Neurotoxicity with combined administration of lithium and a neuroleptic. Prakash R; Kelwala S; Ban TA Compr Psychiatry; 1982; 23(6):567-71. PubMed ID: 6130891 [No Abstract] [Full Text] [Related]
56. What is the role of dopamine in childhood neurological disorders? Kurian MA Dev Med Child Neurol; 2013 Jun; 55(6):493-4. PubMed ID: 23496203 [No Abstract] [Full Text] [Related]
58. The impact of prolactin assays on clinical endocrinology. Thomson JA Scott Med J; 1980 Apr; 25(2):89-90. PubMed ID: 7455677 [No Abstract] [Full Text] [Related]
59. Neuroendocrinological and biochemical effects of chronic neuroleptic treatment. Hippius H; Ackenheil M; Müller-Spahn F Adv Biochem Psychopharmacol; 1985; 40():9-13. PubMed ID: 2862769 [No Abstract] [Full Text] [Related]
60. beta-Endorphin, cortisol, and prolactin in serum of schizophrenic patients during long-term neuroleptic treatment and after withdrawal: relationships to psychopathology. Naber D; Albus M; Muller F; Burke H; Welter D; Ackenheil M; Hippius H Psychopharmacol Bull; 1982 Oct; 18(4):224-6. PubMed ID: 6130563 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]